Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-31 @ 2:15 AM
Study NCT ID:
NCT07391761
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-18
First Post:
2025-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-15
First Submit QC Date:
None
Study First Post Date:
2026-02-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-17
Last Update Post Date:
2026-02-18
Last Update Post Date Type:
ACTUAL